Appel à projets : PHRCI (2019)
Titre : A multicenter, randomised phase II trial evaluating the association of Gadolinium-based nanoparticles (AGuIX) with radiotherapy for the therapeutic management of patients with symptomatic inoperable musculoskeletal tumor lesions (Either inoperable primary lesions or secondary lesions
Acronyme : NANO-RT
Discipline principale : Cancer
Porteur : Coralie MONCHARMONT
Établissement : CENTRE LEON BERARD (CLCC), Auvergne-Rhône-Alpes
Financement total : 213430 €